Belzutifan is an inhibitor that targets HIF-2α. It’s used for RCC related to VHL and works to cut down on tumor hypoxia signaling. You’ll find it in these 40 mg film-coated tablets.
They usually suggest taking 120 mg of it every day. Each bottle comes with 90 tablets.
Reviews
There are no reviews yet.